Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections
病毒感染中的硫化氢和 NRF2 串扰
基本信息
- 批准号:10379874
- 负责人:
- 金额:$ 50.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-11 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:3-Mercaptopyruvate sulfurtransferaseAcetylationAcetylesteraseAcuteAffectAnimal ModelAnti-Inflammatory AgentsAntioxidantsAntiviral ResponseAreaAsthmaBronchiolitisCellsCessation of lifeChildClinicalClinical ResearchCystathionineDataDeacetylationDevelopmentDiseaseElderlyEnzymesEpithelial CellsEquilibriumExperimental ModelsGenerationsGenesGenetic TranscriptionHomeostasisHumanHydrogen SulfideImmunocompromised HostIn VitroInfantInfectionInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInvestigationKnock-outLaboratoriesLeadLinkLower Respiratory Tract InfectionLower respiratory tract structureLungLung diseasesLyaseMammalsMediatingMediator of activation proteinMolecularMorbidity - disease rateMusNF-E2-related factor 2NuclearOxidation-ReductionOxidative StressPathogenesisPathway interactionsPharmacologyPlayPneumoniaPost-Translational Protein ProcessingProductionPublic HealthPublishingPulmonary InflammationReactive Oxygen SpeciesReagentRecurrenceReperfusion InjuryResourcesRespiratory Syncytial Virus InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsRespiratory syncytial virusRiskRoleSeriesSeveritiesSeverity of illnessShockSignal TransductionSumoylation PathwaySyndromeTestingTherapeuticTissuesUbiquitinUbiquitinationVaccinesVascular DiseasesViralViral BronchiolitisViral Load resultViral PathogenesisVirusVirus DiseasesVirus ReplicationWheezingairway epitheliumairway hyperresponsivenessantioxidant enzymeasthma exacerbationcell injurychemokinecohortcytokinedisease phenotypeeffective therapyexperienceexperimental studyfluin vivoinducible gene expressioninnovationlung injurymortalitymouse modelmulticatalytic endopeptidase complexnovelnovel therapeutic interventionnuclear factor-erythroid 2preventrecruitreplication stressrespiratory morbidityrespiratory virusresponse
项目摘要
PROJECT SUMMARY/ABSTRACT
Respiratory syncytial virus (RSV) is a major cause of upper and lower respiratory tract infections (LRTIs) in
children, elderly and immunocompromised hosts, for which no effective treatment or vaccine is available.
Children who develop RSV-induced bronchiolitis are also at increased risk for recurrent wheezing and
development of asthma in later life. Although the pathogenesis of RSV-induced disease remains a matter of
intense scientific debate, increasing evidence from experimental models and studies in naturally acquired
infections suggest that severe LRTIs are indeed associated with increased viral “load” and delayed viral
clearance due to an innate immune response that fails to restrict viral replication, yet causing inflammation and
tissue damage. The endogenously-generated gasotransmitter hydrogen sulfide (H2S) is implicated in a variety
of inflammatory and vascular disorders, associated with both pro- and anti-inflammatory signaling. Recently,
our group has gathered important new data, reagents and animals models that demonstrate a key role of H2S
in mediating antiviral and anti-inflammatory responses in the lung. In particular, we have shown that H2S
potently inhibits viral replication, exerts anti-inflammatory activity, and controls airway hyperresponsiveness in
RSV-infected mice. At the cellular level, we have shown that RSV is capable of inhibiting the expression of
cystathionine γ-lyase (CSE), the key enzyme that generates H2S is the lung, reducing the ability to generate
cellular H2S. We propose that dysregulation of the H2S pathway affects host antiviral response and plays a
critical role in the pathogenesis of severe RSV infections. Our findings indicate an important cross-talk between
H2S and the transcription factor NF-E2-related factor 2 (NRF2)-dependent pathways, which control the cellular
redox balance, each of them exerting a positive influence on the other, and both of them being downregulated
in the course of RSV infection. Thus, in this project, we will test the central hypothesis that inhibition of
cytoprotective H2S generation, due to decreased NRF2-dependent gene transcription, leads to clinical
manifestations of RSV infection. We will employ a combination of in vitro and in vivo approaches to test this
hypothesis, by the use of cells and mice genetically deficient in either NRF2 or H2S generating enzymes, and
the access to our ongoing cohort of infants and young children with primary RSV infections. This project will
elucidate innate pathways by which respiratory viruses modulate lung disease, with strong implications for
developing novel antiviral and anti-inflammatory therapeutic strategies for RSV-induced LRTI and possibly
long-term consequences, such as recurrent wheezing or asthma. Our long-standing clinical and research
expertise in the area of pathogenesis of viral bronchiolitis and RSV infections, strong preliminary data, and
UTMB's outstanding resources in the area of lung disease make us ideally suited to pursue this innovative
project.
项目总结/摘要
呼吸道合胞病毒(RSV)是导致上呼吸道和下呼吸道感染(LRTI)的主要原因,
儿童、老年人和免疫功能低下的宿主,对此没有有效的治疗或疫苗。
患有RSV引起的细支气管炎的儿童也会增加反复喘息的风险,
哮喘在晚年的发展。尽管RSV引起的疾病的发病机制仍然是一个问题,
激烈的科学辩论,越来越多的证据来自实验模型和自然获得的研究。
感染表明,严重的LRTI确实与增加的病毒“负荷”和延迟的病毒感染有关。
由于先天免疫反应而导致的清除,不能限制病毒复制,但会引起炎症,
组织损伤内源性产生的气体递质硫化氢(H2S)与多种
炎症和血管疾病,与促炎和抗炎信号有关。最近,
我们的团队已经收集了重要的新数据、试剂和动物模型,证明了H2S的关键作用
介导肺部的抗病毒和抗炎反应。特别是,我们已经表明,H2S
有效抑制病毒复制,发挥抗炎活性,并控制气道高反应性,
RSV感染的小鼠。在细胞水平上,我们已经证明RSV能够抑制
胱硫醚γ-裂解酶(CSE),产生H2S的关键酶是肺,降低了产生H2S的能力。
细胞内H2S我们认为,H2S途径的失调影响宿主的抗病毒反应,并发挥作用。
在严重RSV感染的发病机制中起关键作用。我们的研究结果表明,
H2S和转录因子NF-E2相关因子2(NRF 2)依赖性途径,这些途径控制细胞内
氧化还原平衡,它们中的每一个都对另一个产生积极的影响,并且它们都被下调
在RSV感染的过程中。因此,在这个项目中,我们将测试中心假设,即抑制
由于NRF 2依赖性基因转录减少,细胞保护性H2S生成导致临床
RSV感染的表现。我们将采用体外和体内相结合的方法来测试这一点
假设,通过使用在NRF 2或H2S生成酶中遗传缺陷的细胞和小鼠,以及
获得我们正在进行的患有原发性RSV感染的婴儿和幼儿队列。该项目将
阐明呼吸道病毒调节肺部疾病的先天途径,
为RSV诱导的LRTI开发新的抗病毒和抗炎治疗策略,
长期后果,如反复喘息或哮喘。我们长期的临床和研究
病毒性细支气管炎和RSV感染发病机制领域的专业知识,强有力的初步数据,以及
UTMB在肺部疾病领域的杰出资源使我们非常适合追求这一创新
项目
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Antonella Casola其他文献
Antonella Casola的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Antonella Casola', 18)}}的其他基金
Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus Infection
缺氧诱导因子 (HIF) 在呼吸道合胞病毒感染中的作用
- 批准号:
10742170 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections
病毒感染中的硫化氢和 NRF2 串扰
- 批准号:
9911341 - 财政年份:2019
- 资助金额:
$ 50.38万 - 项目类别:
Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections
病毒感染中的硫化氢和 NRF2 串扰
- 批准号:
9843442 - 财政年份:2017
- 资助金额:
$ 50.38万 - 项目类别:
A novel role of NF-kB in viral-induced airway oxidative stress
NF-kB 在病毒诱导的气道氧化应激中的新作用
- 批准号:
8784185 - 财政年份:2013
- 资助金额:
$ 50.38万 - 项目类别:
A novel role of NF-kB in viral-induced airway oxidative stress
NF-kB 在病毒诱导的气道氧化应激中的新作用
- 批准号:
8638667 - 财政年份:2013
- 资助金额:
$ 50.38万 - 项目类别:
Innate Immune Response to Human Metapneumovirus Infection
对人类偏肺病毒感染的先天免疫反应
- 批准号:
8661692 - 财政年份:2010
- 资助金额:
$ 50.38万 - 项目类别:
Innate Immune Response to Human Metapneumovirus Infection
对人类偏肺病毒感染的先天免疫反应
- 批准号:
7785949 - 财政年份:2010
- 资助金额:
$ 50.38万 - 项目类别:
Innate Immune Response to Human Metapneumovirus Infection
对人类偏肺病毒感染的先天免疫反应
- 批准号:
8473152 - 财政年份:2010
- 资助金额:
$ 50.38万 - 项目类别:
Innate Immune Response to Human Metapneumovirus Infection
对人类偏肺病毒感染的先天免疫反应
- 批准号:
8282740 - 财政年份:2010
- 资助金额:
$ 50.38万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 50.38万 - 项目类别: